Dee Anna Smith, CEO of Sarah Cannon

Dee Anna Smith is the chief executive officer of Sarah Cannon, the Cancer Institute of HCA Healthcare. Appointed as CEO in 2006, Smith is responsible for leading the organization’s overall mission and vision to make a global impact on cancer research and care. Under her leadership, Sarah Cannon has grown its reach in bringing world-class cancer care closer to home for hundreds of thousands of people facing cancer across the United States and United Kingdom. Additionally, the organization has been a key contributor in clinical research that has led to the majority of newly approved cancer therapies over the last decade. 

Smith has received numerous recognitions for her leadership and community impact on a local and national level. Most recently, she received Pepperdine University’s 2019 Distinguished Alumnus Award. In October 2017, Smith was recognized by Nashville-based Operation Andrew as a Rodgers Award recipient for making an impact on lives and communities in Middle Tennessee and beyond.

Smith is a member of the American Institute of Certified Public Accountants and American Society of Clinical Oncology. She is the chair of the Pepperdine University Board of Regents, and also serves on the board of directors for the Nashville Entrepreneur Center and the Nashville Health Care Council. She received her bachelor’s degree in Accounting from Pepperdine University.

Dee Anna Smith, CEO of Sarah Cannon

Sponsored Content

Sponsored Content